Puma Biotechnology (United States)

Recent papers from Puma Biotechnology (United States)

1. Combining orally available selective estrogen receptor degraders with pan-HER tyrosine kinase inhibitor neratinib in pre-clinical models of HER2+/ER+ breast cancernpj Breast Cancer · 2026
2. Low-level Aurora kinase A amplification: CDK4/6 inhibitor resistance biomarker in hormone receptor-positive metastatic breast cancernpj Precision Oncology · 2026
3. Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket TrialClinical Cancer Research · 2026
4. Editorial: Cellular senescence in aging-related diseases: mechanisms and therapeutic targetsSHILAP Revista de lepidopterología · 2026
5. Abstract 1849: Dual inhibition of AURKA and ERBB overcomes resistance to PI3K/BTK/BCL2 inhibitors in marginal zone lymphoma models.Cancer Research · 2026
6. Abstract 7126: Targeting Aurora A kinase together with alternative survival signaling overcomes resistance to endocrine and CDK4/6 therapies in ER+ breast cancerCancer Research · 2026
7. Abstract PS3-10-28: Randomized phase II trial evaluating three anti-diarrheal prophylaxis strategies in patients (pts) with HER2+/HR+ early breast cancer (EBC) treated with extended adjuvant neratinib (dianer geicam/2018-06)Clinical Cancer Research · 2026
8. Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapiesMolecular Oncology · 2025
9. Engineered Microbial Production of l -Fucose: A Sustainable Biomanufacturing Platform via Genomic Integration and Pathway OptimizationACS Sustainable Chemistry & Engineering · 2025
10. Female-centric soccer cleat prototypes: effects of fatigue and design on pressure distributionFootwear Science · 2025
11. Efficient Biosynthesis of Sialyllacto-N-tetraose a by a Metabolically Engineered Escherichia coli BL21(DE3) StrainJournal of Agricultural and Food Chemistry · 2025
12. Multidimensional Engineering of Escherichia coli MG1655 for the Efficient Biosynthesis of DifucosyllactoseJournal of Agricultural and Food Chemistry · 2025
13. Highly Efficient In Vivo Production of Sialyllacto-N-tetraose C via Screening of Beneficial β1,4-galactosyltransferase and α2,6-sialyltransferaseJournal of Agricultural and Food Chemistry · 2025
14. Turing.jl: A General-Purpose Probabilistic Programming LanguageACM transactions on probabilistic machine learning. · 2025
15. Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies2024
16. Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket TrialClinical Lung Cancer · 2024
17. Untangling the Exposure–Response Relationship of Allopurinol in the Setting of Chronic Kidney Disease and Diuretic Use: Implications for DosingTherapeutic Drug Monitoring · 2024
18. Self-perceived middle-distance race pace is faster in advanced footwear technology spikesJournal of sport and health science/Journal of Sport and Health Science · 2024
19. Neratinib plus dasatinib is highly synergistic in HER2-positive breast cancer in vitro and in vivoTranslational Oncology · 2024
20. Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without mTOR Inhibitors in Patients with Fibrolamellar CarcinomaLiver Cancer · 2024